Analysis MDxHealth SA (0O8G)
5/24/2024
Analysis of MDxHealth SA (0O8G)
Based on the provided data for MDxHealth SA (symbol: 0O8G), here is a short analysis:1. Price Movement:
- The closing price has been fluctuating between 2.82134 and 3.13817 over the past few days.
- The stock closed at 3.01983 on the most recent trading day, showing a slight decrease from the previous day's close.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been consistently above 50, indicating bullish momentum in the stock.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) histogram has been mostly negative, suggesting a bearish trend.
3. Moving Averages:
- The Simple Moving Average (SMA) and Exponential Moving Average (EMA) have been trending upwards, indicating a potential bullish signal.
- The Weighted Moving Average (WMA) also shows an upward trend, supporting the bullish sentiment.
4. Overall:
- The stock has shown signs of bullish momentum with RSI values above 50 and moving averages trending upwards.
- However, the MACD histogram being mostly negative suggests a possible bearish trend in the short term.
Investors should consider these technical indicators along with other fundamental analysis before making any investment decisions in MDxHealth SA.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive profit margin and healthy return on assets and equity. The balance sheet shows a current ratio slightly above 1, indicating good liquidity, but a high total debt to equity ratio. The income statement reflects solid revenue and net income figures, with a positive operating margin.
Moving on to stock statistics, the company has a relatively low short ratio and short percent of shares outstanding. The majority of shares are held by institutions, with a small percentage held by insiders. The stock has a significant market capitalization and enterprise value.
Valuation metrics show a high PEG ratio and price-to-book ratio, with moderate price-to-earnings ratios. The stock price summary includes beta, moving averages, and the 52-week low and high prices.
Lastly, the dividends and splits data indicate a consistent dividend payout, with information on dividend dates, split history, and dividend yields.
Income statement 💸
These are the revenues. Draw conclusions.Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and accounts receivable, with cash and cash equivalents showing fluctuations over the years.
3. Non-current assets consist of investments, machinery, furniture, and equipment, which have been increasing steadily.
4. Total liabilities have also been increasing, with the highest value of $302,083,000,000 in 2022.
5. Current liabilities include short-term debt, accounts payable, and deferred revenue, showing variations over the years.
6. Non-current liabilities consist of long-term debt and other non-current liabilities, which have been on the rise.
7. Shareholders' equity has shown fluctuations but has generally increased over the years, with the highest value of $107,147,000,000 in 2018.
Overall, the company's assets, liabilities, and shareholders' equity have been growing, with some fluctuations in specific components.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods, with the highest growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience double-digit growth over the next 5 years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the average and median both indicating a price higher than the current price. The low and high ends of the forecast suggest a wide range of potential outcomes. It's important to consider these different perspectives when making investment decisions.
MACD of 0O8G
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
